| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 55.68B | 55.51B | 52.98B | 46.79B | 37.69B | 31.66B |
| Gross Profit | 17.71B | 17.40B | 14.99B | 11.52B | 10.44B | 9.85B |
| EBITDA | 6.52B | 6.47B | 4.92B | 2.34B | 2.11B | 2.28B |
| Net Income | 4.94B | 4.32B | 3.01B | 899.00M | 273.00M | 978.00M |
Balance Sheet | ||||||
| Total Assets | 62.46B | 63.40B | 62.17B | 56.28B | 51.09B | 48.37B |
| Cash, Cash Equivalents and Short-Term Investments | 10.47B | 12.38B | 12.34B | 8.03B | 7.26B | 8.08B |
| Total Debt | 5.69B | 5.95B | 6.59B | 7.57B | 6.29B | 6.93B |
| Total Liabilities | 18.05B | 18.43B | 19.53B | 19.29B | 17.21B | 16.20B |
| Stockholders Equity | 42.92B | 43.43B | 40.20B | 34.65B | 31.44B | 30.13B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.04B | 3.84B | -351.00M | -104.00M | 917.00M |
| Operating Cash Flow | 0.00 | 4.80B | 4.30B | 174.00M | 294.00M | 1.57B |
| Investing Cash Flow | 0.00 | -1.14B | 413.00M | 59.00M | -733.00M | -555.00M |
| Financing Cash Flow | 0.00 | -2.41B | -1.60B | -83.00M | -1.42B | 208.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥45.32B | 5.81 | ― | 3.53% | -5.41% | 31.52% | |
74 Outperform | ¥196.73B | 8.69 | ― | 4.09% | -1.41% | -13.30% | |
71 Outperform | ¥119.77B | 17.82 | ― | 0.67% | 5.45% | -7.61% | |
69 Neutral | ¥320.14B | 10.96 | ― | 5.28% | -2.01% | 19.12% | |
67 Neutral | ¥102.32B | 10.01 | ― | 3.88% | -3.89% | -3.31% | |
64 Neutral | ¥29.99B | 6.94 | ― | 3.53% | 4.47% | 9.89% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |